In conclusion, treatment with iSGLT2 induced a downregulation of DPP4 protein levels, whereas silencing of SIRT3 induced an increase in DPP4 protein levels, suggesting a new signaling network in CRC cells. The gene discussed is DPP4; the disease is colorectal carcinoma.